P-115 - PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELS MODEL TO INFORM THE RISKS ASSOCIATED WITH NATURAL ā€ˇMONOAMINE OXIDASE INHIBITORS.
F. Martins1, R. Bonan2, S. Schaller1, J. Junior3, R. Costa3, A. Diniz2, S. Sy2; 1esqLABS GmbH, Saterland, Germany, 2State University of Maringá, Maringá, Paraná, Brazil, 3Federal University of Pará, Para, Brazil.